Rigel Pharmaceuticals will present updated data from its ongoing Phase 1b study of R289, a dual IRAK1/4 inhibitor, in patients with relapsed or refractory lower-risk myelodysplastic syndrome (MDS) at the 2026 ASH Annual Meeting. The data will include efficacy and safety results from the dose expansion phase, showing potential reduction in transfusion dependence. Additionally, three poster presentations will highlight findings on TAVALISSE (fostamatinib) for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), including real-world safety and effectiveness data. These presentations underscore Rigel's progress in developing treatments for hematologic disorders and cancer.
Rigel Pharmaceuticals' presentation of Phase 1b data for R289 in lower-risk MDS patients comes as 127 of 150 health-sector US stocks on Pluang rose today. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 04, 2026 20:41 WIB: HCA Health Inc (HCA) rose 7.16% to USD 496.00 with a typical hold time of 77 days; Medline Inc. Class A (MDLN) increased 7.10% to USD 36.51 with 98% buy order activity and a 9-day typical hold time; Tenet Healthcare Corporation (THC) fell 5.94% to USD 282.52 with 100% sell order activity and a 17-day typical hold time.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
